The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C
- 30 April 2004
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Hepatology
- Vol. 40 (4), 675-681
- https://doi.org/10.1016/j.jhep.2003.12.014
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Cost effectiveness of peginterferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis CGut, 2003
- Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patientsHepatology, 2002
- Neuropsychological impairment in patients with chronic hepatitis CHepatology, 2002
- The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivityJournal of Hepatology, 2001
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994The New England Journal of Medicine, 1999
- Health-related quality of life in chronic hepatitis C: Impact of disease and treatment responseHepatology, 1999
- Hepatitis C virus infection: quality of life and side effects of treatmentJournal of Hepatology, 1999
- Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapyHepatology, 1999
- Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosisHepatology, 1998
- National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis CHepatology, 1997